Diabetes drugs may protect against Parkinson’s
Scientists published a new study that says patients with diabetes, who were treated with glitazone had a 28% reduced risk of developing Parkinson’s disease. Glitazone are so called “peroxisome proliferation-activated receptor gamma (PPARɣ) agonists”. A very complicated name that describes the way these drugs work. It has been suggested before that the same mechanism could